Menu
03/11/2003
Scientists claim to have found 'obesity gene'
An international team of researchers is claiming to have identified the role of a gene which may explain why some people overeat and become obese.
Their research, published today in the Public Library of Science Biology, found that the gene GAD2 has an appetite stimulating role, and that one form of the gene is strongly associated with obese people.
While the researchers recognise that obesity is a result of the interactions of many genes and environmental factors, this is one of the first genes to be strongly touted as a candidate gene for obesity.
GAD2 acts by speeding up production of a neurotransmitter in the brain called GABA, or gamma-amino butyric acid. When GABA interacts with another molecule named neuropeptide Y in a specific area of the brain - the paraventricular nucleus of the hypothalamus - we are stimulated to eat, the report said.
The researchers behind this study believe that people who carry a more active form of the GAD2 gene build up a larger than normal quantity of GABA in the hypothalamus, and suggest that this over-accumulation of GABA drives the stimulus to eat further than normal, and is thus a basis for explaining why obese people overeat.
Professor Philippe Froguel, senior author of the research, from Imperial College London, and Hammersmith Hospital, London, and who carried out the research while at the Institut Pasteur de Lille, France, said: "Genetic factors alone can not explain the rapid rise in obesity rates, but they may provide clues to preventative and therapeutic approaches that will ease the health burden associated with obesity.
"Having identified this gene, it may be possible to develop a screening programme to identify those who may be at risk of becoming obese later in life, and take effective preventative measures."
(gmcg)
Their research, published today in the Public Library of Science Biology, found that the gene GAD2 has an appetite stimulating role, and that one form of the gene is strongly associated with obese people.
While the researchers recognise that obesity is a result of the interactions of many genes and environmental factors, this is one of the first genes to be strongly touted as a candidate gene for obesity.
GAD2 acts by speeding up production of a neurotransmitter in the brain called GABA, or gamma-amino butyric acid. When GABA interacts with another molecule named neuropeptide Y in a specific area of the brain - the paraventricular nucleus of the hypothalamus - we are stimulated to eat, the report said.
The researchers behind this study believe that people who carry a more active form of the GAD2 gene build up a larger than normal quantity of GABA in the hypothalamus, and suggest that this over-accumulation of GABA drives the stimulus to eat further than normal, and is thus a basis for explaining why obese people overeat.
Professor Philippe Froguel, senior author of the research, from Imperial College London, and Hammersmith Hospital, London, and who carried out the research while at the Institut Pasteur de Lille, France, said: "Genetic factors alone can not explain the rapid rise in obesity rates, but they may provide clues to preventative and therapeutic approaches that will ease the health burden associated with obesity.
"Having identified this gene, it may be possible to develop a screening programme to identify those who may be at risk of becoming obese later in life, and take effective preventative measures."
(gmcg)
Related UK National News Stories
Click here for the latest headlines.
10 July 2009
Gene Defect Linked To Allergy, BMJ Finds
Defects in a particular gene - the filaggrin gene - are associated with a significantly increased risk of developing allergic disorders such as eczema, rhinitis, and asthma, concludes a study published on bmj.com today. Allergic diseases have increased in recent decades and now affect up to one in three children in economically developed countries.
Gene Defect Linked To Allergy, BMJ Finds
Defects in a particular gene - the filaggrin gene - are associated with a significantly increased risk of developing allergic disorders such as eczema, rhinitis, and asthma, concludes a study published on bmj.com today. Allergic diseases have increased in recent decades and now affect up to one in three children in economically developed countries.
24 June 2003
£50m funding unveiled for NHS gene research
The government is set to promote the development of genetics within the NHS following its decision to plough £50 million into the scheme over the next three years. The White Paper 'Our Inheritance, Our Future - Realising the potential of genetics in the NHS' sets out the government's strategy.
£50m funding unveiled for NHS gene research
The government is set to promote the development of genetics within the NHS following its decision to plough £50 million into the scheme over the next three years. The White Paper 'Our Inheritance, Our Future - Realising the potential of genetics in the NHS' sets out the government's strategy.
02 August 2004
Gene therapy trial for cancer patients gets green light
The green light has been given for a large clinical trial of a new gene therapy treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure. The new gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients.
Gene therapy trial for cancer patients gets green light
The green light has been given for a large clinical trial of a new gene therapy treatment for patients with Glioma - one of the most aggressive types of brain tumours for which there is currently no cure. The new gene therapy treatment involves injecting Herpes simplex virus into the brain tumours of Glioma patients.
18 July 2003
Depression lies in our DNA, scientists claim in new study
Scientists have claimed that depression could lie in our DNA, after a study is published suggesting that people with a specific version of a gene are afforded greater protection against the illness. The gene – known as 5-TTT – is involved in the regulation of serotonin, a chemical which assists communication between brain cells.
Depression lies in our DNA, scientists claim in new study
Scientists have claimed that depression could lie in our DNA, after a study is published suggesting that people with a specific version of a gene are afforded greater protection against the illness. The gene – known as 5-TTT – is involved in the regulation of serotonin, a chemical which assists communication between brain cells.
29 March 2004
Research in genetic disorders gets £4m funding boost
The government has said that it will plough £3 million into clinical trials and research into the genetic disorders of haemophilia, muscular dystrophy and childhood blindness. A further £1 million will be used to support research into the long-term safety of some techniques used in gene therapy, the Health Secretary John Reid said today.
Research in genetic disorders gets £4m funding boost
The government has said that it will plough £3 million into clinical trials and research into the genetic disorders of haemophilia, muscular dystrophy and childhood blindness. A further £1 million will be used to support research into the long-term safety of some techniques used in gene therapy, the Health Secretary John Reid said today.
-
Northern Ireland WeatherThis Evening and Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
